.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX40_OmacetaxineMepesuccinate.OmacetaxineMepesuccinate .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01X_OtherAntineoplasticAgents.L01XX40_OmacetaxineMepesuccinate.OmacetaxineMepesuccinate| name: | OmacetaxineMepesuccinate |
| ATC code: | L01XX40 | route: | subcutaneous |
| n-compartments | 2 |
Omacetaxine mepesuccinate (also known as homoharringtonine) is an alkaloid antineoplastic agent approved for the treatment of chronic myeloid leukemia (CML) in adults with resistance and/or intolerance to two or more tyrosine kinase inhibitors.
Pharmacokinetics reported in adult patients with chronic or accelerated phase chronic myeloid leukemia receiving subcutaneous administration.